Skip to content
Recall Observatory FDA recall evidence

Drug product

SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.

D-1350-2022

July 21, 2022

Class I

Product summary

Firm
Ultra Supplement LLC
Event
Event 90659
Status
Terminated
Classification
Class I
Quantity
750 cartons
Official record key
drug-enforcement:D-1350-2022

Official wording

Reason: Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.

Code information: Lot DAP272109, Exp: 4/1/2026

Distribution pattern: Product was distributed nationwide in the USA via Amazon Marketplace on www.amazon.com.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.